DailyIQ
|
Sector:Financial ServicesAll sectors
Last updated 1 minute ago

MET·MetLife, Inc.

$.
+. (+.%)
After Hours
High
$92.49
Open
$92.06
Market Cap
58.92B
52W High
$92.27
Low
$91.14
P. Close
$91.64
P/E
16.28
52W Low
$67.33
Fwd P/E
8.32
DailyIQ Est.
$96.29
Technical Score (1D)
95
BUY
News Sentiment
73
BULLISH
Jefferies has lifted its price target for MetLife from $97 to $103 while keeping a Buy rating, signalling a stronger view of the insurer’s future earnings. The upgrade reflects the firm’s confidence that MetLife’s underwriting performance will continue to improve, which should support the company’s cash‑flow generation over the next few quarters. A higher target price suggests that analysts expect a more robust earnings trajectory, which could buoy investor sentiment in the life‑insurance sector. This bullish outlook may lead traders to re‑evaluate their positions ahead of the upcoming earnings release. The earnings report will be a key catalyst, as it will confirm whether underwriting gains materialize as projected. Additionally, any regulatory updates that could affect capital requirements or product offerings will be closely monitored. Market participants should watch for the earnings announcement and any commentary on regulatory developments that could alter the risk profile of the insurer. If underwriting results exceed expectations, the stock could see a positive reaction; conversely, weaker results or adverse regulatory news could dampen the rally. Traders should therefore keep a close eye on the earnings call and any subsequent regulatory filings for signals that could shift the market’s perception of MetLife’s growth prospects.
Earnings Summary
MetLife, Inc. is a global financial services provider specializing in insurance, annuities, employee benefits, and asset management, operating through six primary segments that serve a diverse international clientele. In the life‑insurance sector, the company has maintained a broad product portfolio that includes life, health, disability, and retirement solutions, positioning it as a significant player in the financial services industry. Over the past two fiscal quarters, MetLife’s earnings per share fell from $2.58 in Q4 2025 to $2.42 in Q1 2026, while revenue declined from $24.191 billion to $19.682 billion, reflecting a modest contraction after a strong fourth‑quarter performance; the prior two quarters saw EPS rise from $2.02 in Q2 2025 to $2.37 in Q3 2025 and revenue increase from $17.921 billion to $17.901 billion, indicating a period of incremental growth that was followed by a reversal in the most recent quarter. Historically, MetLife has posted a mixed earnings trajectory, with EPS beating analyst estimates in three of the last six quarters—Q3 2025, Q4 2025, and Q1 2026—while revenue growth has been uneven, peaking in Q4 2025 before declining in Q1 2026; the company has consistently met or exceeded revenue expectations in the majority of reporting periods, suggesting resilience in its top‑line despite occasional EPS misses. Recent analyst activity underscores a bullish outlook, as UBS and Barclays have lifted price targets to $105 and $94 respectively, citing stronger underwriting results and disciplined capital allocation; the board’s declaration of a third‑quarter 2026 dividend of $0.5925 per share further signals confidence in cash‑flow generation. Investors should watch for upcoming earnings guidance on underwriting performance, loss ratios, and capital deployment, as well as the sustainability of the announced dividend in light of future capital needs.

EPS

EstBeatMiss
$1.87$2.07$2.27$2.47$2.67Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.34 - -
Q1'26$2.27$2.42+6.6%
Q4'25$2.37$2.58+9.1%
Q3'25$2.32$2.37+2.2%
Q2'25$2.16$2.02-6.7%
Q1'25$2.01$1.96-2.5%

Revenue

EstBeatMiss
$16.4B$19.7B$23.0B$26.2B$29.5BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$20.0B - -
Q1'26$19.4B$19.7B+1.3%
Q4'25$28.0B$24.2B-13.6%
Q3'25 - $17.9B -
Q2'25 - $17.9B -
Q1'25 - $18.8B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MET Stock Snapshot

MET is currently trading at $91.87, giving MetLife, Inc. a market cap of 58.92B and a P/E ratio of 16.3. Today's range spans $91.14–$92.49, with shares opening at $92.06 and moving up $0.23 (0.3%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 73/100.

Over the past year MET has traded between $67.33 and $92.27 - the current price is +36.4% off the 52-week low and -0.4% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $93.81 (range $75.00–$106.00), implying upside of +2.1%.

Cross-asset context supports the bullish read on MET: when Financial Services sector conditions are favorable, large-cap names with 95/100 technical scores (BUY) and bullish sentiment (73/100) outperform on a risk-adjusted basis. Price: $91.87 (near 52-week highs). (P/E: 16.3) The 52-week context of $67.33–$92.27 shows the full trading history - and the current setup is one of the stronger entries within that range. At 58.92B in market cap, position sizing is the key variable, not the direction.

Earnings revision cycles in large-cap Financial Services names tend to compound: when technicals confirm a BUY thesis (95/100) and news sentiment (73/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $91.87 (near 52-week highs), MET's position within the $67.33–$92.27 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.